104
|
256
|
2ivxA |
Crystal structure of human cyclin t2 at 1.8 a resolution |
95
|
257
|
2iw9B |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
101
|
254
|
2i53A |
Crystal structure of cyclin k |
95
|
257
|
2i40B |
Cdk2/cyclin a complexed with a thiophene carboxamide inhibitor |
135
|
388
|
2g77A |
Crystal structure of gyp1 tbc domain in complex with rab33 gtpase bound to gdp and alf3 |
97
|
262
|
2g9xB |
Structure of thr 160 phosphorylated cdk2/cyclin a in complex with the inhibitor nu6271 |
88
|
247
|
2eufA |
X-ray structure of human cdk6-vcyclin in complex with the inhibitor pd0332991 |
83
|
247
|
2f2cA |
X-ray structure of human cdk6-vcyclinwith the inhibitor aminopurvalanol |
46
|
152
|
2dxbB |
Recombinant thiocyanate hydrolase comprising partially-modified cobalt centers |
62
|
227
|
2dppB |
Crystal structure of thermostable bacillus sp. rapc8 nitrile hydratase |
47
|
152
|
2dxcB |
Recombinant thiocyanate hydrolase, fully-matured form |
26
|
120
|
2dmeA |
Solution structure of the tfiis domain ii of human phd finger protein 3 |
58
|
212
|
2d0qB |
Complex of fe-type nhase with cyclohexyl isocyanide, photo-activated for 1hr at 277k |
47
|
152
|
2dd4B |
Thiocyanate hydrolase (scnase) from thiobacillus thioparus recombinant apo-enzyme |
59
|
211
|
2cz1B |
Photo-activation state of fe-type nhase with n-ba in anaerobic condition |
60
|
212
|
2cz6B |
Complex of inactive fe-type nhase with cyclohexyl isocyanide |
48
|
152
|
2dd5B |
Thiocyanate hydrolase (scnase) from thiobacillus thioparus native holo-enzyme |
56
|
211
|
2cyzB |
Photo-activation state of fe-type nhase in anaerobic condition |
58
|
212
|
2cz7B |
Fe-type nhase photo-activated for 75min at 105k |
56
|
211
|
2cz0B |
Photo-activation state of fe-type nhase in aerobic condition |
101
|
260
|
2cchB |
The crystal structure of cdk2 cyclin a in complex with a substrate peptide derived from cdc modified with a gamma-linked atp analogue |
94
|
258
|
2c5oB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
96
|
258
|
2c5nB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
95
|
257
|
2cjmB |
Mechanism of cdk inhibition by active site phosphorylation: cdk2 y15p t160p in complex with cyclin a structure |
97
|
258
|
2c6tB |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
97
|
258
|
2c4gB |
Structure of cdk2-cyclin a with pha-533514 |
86
|
258
|
2c5xB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
244
|
655
|
2bs3A |
Glu c180 -> gln variant quinol:fumarate reductase from wolinella succinogenes |
98
|
258
|
2cciB |
Crystal structure of phospho-cdk2 cyclin a in complex with a peptide containing both the substrate and recruitment sites of cdc6 |
98
|
258
|
2c5vB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
236
|
655
|
2bs4A |
Glu c180 -> ile variant quinol:fumarate reductase fromwolinella succinogenes |
94
|
258
|
2bpmB |
Structure of cdk2-cyclin a with pha-630529 |
244
|
655
|
2bs2A |
Quinol:fumarate reductase from wolinella succinogenes |
94
|
257
|
2bkzB |
Structure of cdk2-cyclin a with pha-404611 |
73
|
254
|
2b9rA |
Crystal structure of human cyclin b1 |
55
|
211
|
2ahjB |
Nitrile hydratase complexed with nitric oxide |
77
|
227
|
1zp2A |
Structure of the mediator subunit cyclin c |
78
|
246
|
1xo2A |
Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin |
95
|
258
|
1vywB |
Structure of cdk2/cyclin a with pnu-292137 |
96
|
270
|
1w98B |
The structural basis of cdk2 activation by cyclin e |
92
|
252
|
1vinA |
Bovine cyclin a3 |
62
|
229
|
1v29B |
Crystal structure of nitrile hydratase from a thermophile bacillus smithii |
58
|
149
|
1unlD |
Structural mechanism for the inhibition of cd5-p25 from the roscovitine, aloisine and indirubin. |
99
|
258
|
1urcB |
Cyclin a binding groove inhibitor ace-arg-lys-leu-phe-gly |
50
|
147
|
1unhD |
Structural mechanism for the inhibition of cdk5-p25 by roscovitine, aloisine and indirubin. |
56
|
149
|
1ungD |
Structural mechanism for the inhibition of cdk5-p25 by roscovitine, aloisine and indirubin. |
66
|
228
|
1ugsB |
Crystal structure of ay114t mutant of co-type nitrile hydratase |
68
|
226
|
1ugpB |
Crystal structure of co-type nitrile hydratase complexed with n-butyric acid |
65
|
228
|
1ugrB |
Crystal structure of at109s mutant of co-type nitrile hydratase |
65
|
228
|
1ugqB |
Crystal structure of apoenzyme of co-type nitrile hydratase |